Short answer
Protara Therapeutics, Inc. (TARA) filed an 8-K current report with the SEC on March 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Protara Therapeutics (TARA) filed earnings results via Exhibit 99.1 press release: full financials contained in that exhibit.
Protara Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Protara Therapeutics (TARA) filed earnings results via Exhibit 99.1 press release: full financials contained in that exhibit
- Furnished (not "filed") under SEC rules, meaning no Section 18 liability: standard practice for earnings releases
- Investors should reference Exhibit 99.1 directly for revenue, cash position, and pipeline-related financial details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Protara Therapeutics, Inc. 8-K filings
Get the next TARA 8-K as it lands
Follow TARA for push alerts, or ask the research agent what this filing means.